Randomized phase II trial of gemcitabine plus S-1 combination therapy versus S-1 in advanced biliary tract cancer: Results of the Japan Clinical Oncology Group study (JCOG0805).
Chigusa Morizane
Honoraria - Novartis
Takuji Okusaka
Honoraria - Lilly; Taiho Pharmaceutical
Research Funding - Lilly; Taiho Pharmaceutical
Junki Mizusawa
No relevant relationships to disclose
Atsuo Takashima
No relevant relationships to disclose
Makoto Ueno
No relevant relationships to disclose
Masafumi Ikeda
No relevant relationships to disclose
Yasuo Hamamoto
No relevant relationships to disclose
Hiroshi Ishii
Honoraria - Lilly
Narikazu Boku
No relevant relationships to disclose
Junji Furuse
Consultant or Advisory Role - Bayer; Chugai Pharma; Eisai
Honoraria - Bayer; Lilly; Taiho Pharmaceutical